Previous Article | Next Article 
Journal of Virology, December 2000, p. 10950-10957, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Hepatitis A Virus-Specific Immunoglobulin A
Mediates Infection of Hepatocytes with Hepatitis A Virus via the
Asialoglycoprotein Receptor
Andreas
Dotzauer,1,*
Ulrike
Gebhardt,1
Karen
Bieback,1
Ulrich
Göttke,1
Anja
Kracke,1
Jörg
Mages,1
Stanley M.
Lemon,2 and
Angelika
Vallbracht1
Department of Virology, University of Bremen,
D-28359 Bremen, Germany,1 and Department
of Microbiology and Immunology, The University of Texas Medical
Branch at Galveston, Galveston, Texas
77555-10192
Received 25 May 2000/Accepted 30 August 2000
The mechanisms underlying the hepatotropism of hepatitis A virus
(HAV) and the relapsing courses of HAV infections are unknown. In this
report, we show for a mouse hepatocyte model that HAV-specific immunoglobulin A (IgA) mediates infection of hepatocytes with HAV via
the asialoglycoprotein receptor, which binds and internalizes IgA
molecules. Proof of HAV infection was obtained by detection of HAV
minus-strand RNA, which is indicative for virus replication, and
quantification of infectious virions. We demonstrate that human
hepatocytes also ingest HAV-anti-HAV IgA complexes by the same
mechanism, resulting in infection of the cells, by using the HepG2 cell
line and primary hepatocytes. The relevance of this surrogate receptor
mechanism in HAV pathogenesis lies in the fact that HAV, IgA, and
antigen-IgA complexes use the same pathway within the organism, leading
from the gastrointestinal tract to the liver via blood and back to the
gastrointestinal tract via bile fluid. Therefore, HAV-specific IgA
antibodies produced by gastrointestinal mucosa-associated lymphoid
tissue may serve as carrier and targeting molecules, enabling and
supporting HAV infection of IgA receptor-positive hepatocytes and, in
the case of relapsing courses, allowing reinfection of the liver in the presence of otherwise neutralizing antibodies, resulting in
exacerbation of liver disease.
*
Corresponding author. Mailing address: Department of
Virology, University of Bremen, Leobener Strasse/UFT, D-28359 Bremen, Germany. Phone: 49 421 218 4354. Fax: 49 421 218 4266. E-mail: dotzauer{at}uni-bremen.de.
Journal of Virology, December 2000, p. 10950-10957, Vol. 74, No. 23
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Snooks, M. J., Bhat, P., Mackenzie, J., Counihan, N. A., Vaughan, N., Anderson, D. A.
(2008). Vectorial Entry and Release of Hepatitis A Virus in Polarized Human Hepatocytes. J. Virol.
82: 8733-8742
[Abstract]
[Full Text]
-
Paulmann, D., Magulski, T., Schwarz, R., Heitmann, L., Flehmig, B., Vallbracht, A., Dotzauer, A.
(2008). Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J. Gen. Virol.
89: 1593-1604
[Abstract]
[Full Text]
-
Tami, C., Silberstein, E., Manangeeswaran, M., Freeman, G. J., Umetsu, S. E., DeKruyff, R. H., Umetsu, D. T., Kaplan, G. G.
(2007). Immunoglobulin A (IgA) Is a Natural Ligand of Hepatitis A Virus Cellular Receptor 1 (HAVCR1), and the Association of IgA with HAVCR1 Enhances Virus-Receptor Interactions. J. Virol.
81: 3437-3446
[Abstract]
[Full Text]
-
Dotzauer, A., Brenner, M., Gebhardt, U., Vallbracht, A.
(2005). IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor. J. Gen. Virol.
86: 2747-2751
[Abstract]
[Full Text]
-
Fensterl, V., Grotheer, D., Berk, I., Schlemminger, S., Vallbracht, A., Dotzauer, A.
(2005). Hepatitis A Virus Suppresses RIG-I-Mediated IRF-3 Activation To Block Induction of Beta Interferon. J. Virol.
79: 10968-10977
[Abstract]
[Full Text]
-
Decot, V., Woerly, G., Loyens, M., Loiseau, S., Quatannens, B., Capron, M., Dombrowicz, D.
(2005). Heterogeneity of Expression of IgA Receptors by Human, Mouse, and Rat Eosinophils. J. Immunol.
174: 628-635
[Abstract]
[Full Text]
-
Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P., Kohn, L. D.
(2002). Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes. J. Virol.
77: 546-559
[Abstract]
[Full Text]
-
Brack, K., Berk, I., Magulski, T., Lederer, J., Dotzauer, A., Vallbracht, A.
(2002). Hepatitis A Virus Inhibits Cellular Antiviral Defense Mechanisms Induced by Double-Stranded RNA. J. Virol.
76: 11920-11930
[Abstract]
[Full Text]
-
Tozawa, R.-i., Ishibashi, S., Osuga, J.-i., Yamamoto, K., Yagyu, H., Ohashi, K., Tamura, Y., Yahagi, N., Iizuka, Y., Okazaki, H., Harada, K., Gotoda, T., Shimano, H., Kimura, S., Nagai, R., Yamada, N.
(2001). Asialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit. ITS OBLIGATE REQUIREMENT FOR THE STABLE EXPRESSION OF OLIGOMERIC RECEPTOR. J. Biol. Chem.
276: 12624-12628
[Abstract]
[Full Text]
-
Rensen, P. C. N., Sliedregt, L. A. J. M., Ferns, M., Kieviet, E., van Rossenberg, S. M. W., van Leeuwen, S. H., van Berkel, T. J. C., Biessen, E. A. L.
(2001). Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytes in Vitro and in Vivo. J. Biol. Chem.
276: 37577-37584
[Abstract]
[Full Text]